Enamel matrix derivative protein stimulated wound healing via phosphoinositide 3-kinase

Journal of Periodontology

Volumn 80, Issue 10, 2009, Pages 1631-1637

  Goda, Seiji ^a   Kaneshita, Yuki ^a   Inoue, Hiroshi ^a   Domae, Eisuke ^a   Ikeo, Takashi ^a   Iida, Joji ^b   Domae, Naochika ^a  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bone biology; Osteoblast(s); Periodontal regeneration; Wound healing

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; WORTMANNIN;

ANIMAL; ARTICLE; CELL COUNT; CELL CULTURE; CELL LINE; CELL MOTION; CELL PROLIFERATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; OSTEOBLAST; PHOSPHORYLATION; WESTERN BLOTTING; WOUND HEALING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BLOTTING, WESTERN; CELL COUNT; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMONES; DENTAL ENAMEL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MORPHOLINES; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; WOUND HEALING;

EID: 70349690227     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090127     Document Type: Article

References (32)

1. Heijl L, Heden G, Svärdström G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714. (Pubitemid 127731614)
2. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-677.
3. Boyan BD, Weesner TC, Lohmann CH, et al. Porcine fetal enamel matrix derivative enhances bone formation induced by demineralized freeze dried bone allograft in vivo. J Periodontol 2000;71:1278-1286.
4. Hoang AM, Oates TW, Cochran DL. In vitro wound healing responses to enamel matrix derivative. J Periodontol 2000;71:1270-1277.
5. Schwartz Z, Carnes DL Jr., Pulliam R, et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontol 2000;71:1287-1296.
6. Ottoson NC, Pribila JT, Chan AS, Shimizu Y. Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase. J Immunol 2001;167:1857-1861.
7. Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003;4:313-319.
8. Fruman DA, Cantley LC. Phosphoinositide 3-kinase in immunological systems. Semin Immunol 2002;14:7-18.
9. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001;17:615-675.
10. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-1657.
11. Giannobile WV, SomermanMJ. Growth and amelogeninlike factors in periodontal wound healing. A systematic review. Ann Periodontol 2003;8:193-204.
12. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
13. Shimizu Y, Hunt SW 3rd. Regulating integrin-mediated adhesion: One more function for PI 3-kinase? Immunol Today 1996;17:565-573.
14. Cain RJ, Ridley AJ. Phosphoinositide 3-kinases in cell migration. Biol Cell 2009;101:13-29.
15. Sasaki T, Irie-Sasaki J, Jones RG, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000;287: 1040-1046.
16. El-Kholy W, Macdonald PE, Lin JH, et al. The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism. FASEB J 2003;17:720-722.
17. Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase. Bioessays 1994;16:565-576.
18. Ward SG, June CH, Olive D. PI 3-kinase: A pivotal pathway in T-cell activation? Immunol Today 1996; 17:187-197.
19. Matsuda N, Horikawa M, Watanabe M, Kitagawa S, Kudo Y, Takata T. Possible involvement of extracellular signal-regulated kinases 1/2 in mitogenic response of periodontal ligament cells to enamel matrix derivative. Eur J Oral Sci 2002;110:439-444.
20. Franke TF, Cantley LC. Apoptosis. A bad kinase makes good. Nature 1997;390:116-117.
21. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: More than just a road to PKB. Biochem J 2000;346:561-576.
22. Alessi DR, Deak M, Casamayor A, et al. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): Structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 1997;7:776-789.
23. Suzuki S, Nagano T, Yamakoshi Y, et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-{beta}. J Dent Res 2005;84:510-514.
24. Jeong HW, Kim IS. TGF-beta1 enhances betaig-h3-mediated keratinocyte cell migration through the alpha3beta1 integrin and PI3K. J Cell Biochem 2004; 92:770-780.
25. Oh JE, Kook JK, Min BM. Beta ig-h3 induces keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin alpha3beta1 and the phosphatidylinositol 3-kinase/ Akt signaling pathway. J Biol Chem 2005;280:21629-21637.
26. Fiedler J, Röderer G, Günther KP, Brenner RE. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002;87:305-312.
27. Kennard S, Liu H, Lilly B. Transforming growth factorbeta (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem 2008;283:1324-1333.
28. Janssens K, ten Dijke P, Janssens S, Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev 2005;26:743-774.
29. Reddi AH. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 1992;4:850-855.
30. Tilghman RW, Slack-Davis JK, Sergina N, et al. Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. J Cell Sci 2005;118:2613-2623.
31. Goda S, Quale AC, Woods ML, Felthauser A, Shimizu Y. Control of TCR-mediated activation of beta 1 integrins by the ZAP-70 tyrosine kinase interdomain B region and the linker for activation of T cells adapter protein. J Immunol 2004;172:5379-5387.
32. Pribila JT, Quale AC, Mueller KL, Shimizu Y. Integrins and T cell-mediated immunity. Annu Rev Immunol 2004;22:157-180.